Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
about
Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Peritherapeutic Serum p53 Anti ...... vant Chemotherapy and Surgery.
@en
Peritherapeutic Serum p53 Anti ...... vant Chemotherapy and Surgery.
@nl
type
label
Peritherapeutic Serum p53 Anti ...... vant Chemotherapy and Surgery.
@en
Peritherapeutic Serum p53 Anti ...... vant Chemotherapy and Surgery.
@nl
prefLabel
Peritherapeutic Serum p53 Anti ...... vant Chemotherapy and Surgery.
@en
Peritherapeutic Serum p53 Anti ...... vant Chemotherapy and Surgery.
@nl
P2093
P2860
P1476
Peritherapeutic Serum p53 Anti ...... vant Chemotherapy and Surgery.
@en
P2093
Kiyokazu Nakajima
Koji Tanaka
Kotaro Yamashita
Makoto Yamasaki
Masaaki Yamamoto
Shuji Takiguchi
Tomoki Makino
Tsuyoshi Takahashi
Yasuhiro Miyazaki
Yukinori Kurokawa
P2860
P2888
P304
P356
10.1007/S00268-017-3894-X
P577
2017-01-20T00:00:00Z